The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Durnova N.A.
V.I. Razumovsky Saratov State Medical University;
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Neurobiological potential of astragaloside IV and prospects for its use in the treatment of Alzheimer’s disease
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(2): 7‑12
Views: 666
Downloaded: 1
To cite this article:
Berezutsky MA, Durnova NA, Kurchatova MN, Matvienko UA. Neurobiological potential of astragaloside IV and prospects for its use in the treatment of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry.
2025;125(2):7‑12. (In Russ.)
https://doi.org/10.17116/jnevro20251250217
The review presents an analysis of experimental data on the study of the neurobiological effects of astragaloside IV, which can be used in the treatment of Alzheimer’s disease. Astragaloside IV is a cycloartan triterpene saponin, which is found in the roots of membranous milk vetch (Astragalus membranaceus (Fisch. ex Link) Bunge) and has a very wide range of pharmacological activity. In recent years, this compound has attracted attention due to its diverse neurobiological effects. Studies have shown the ability of astragaloside IV to modulate microglial activity. The protective effect of this saponin on neurons from the effects of glutamate-induced neurotoxicity has been demonstrated. In PC12 cells, astragaloside IV is shown to be able to resolve various types of mitochondrial dysfunction and inhibit endoplasmic reticulum stress. This compound is also a PPARγ agonist. In vivo experiments have shown that the test substance effectively protects synapses as well as improves cognitive functions, including memory and learning. It is concluded that astragaloside IV, apparently, may be used in the future as a multi-purpose complex therapy for Alzheimer’s disease.
Keywords:
Authors:
Durnova N.A.
V.I. Razumovsky Saratov State Medical University;
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Received:
03.09.2024
Accepted:
01.11.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.